Animals used in processing.
New Orleans City Code § 82-517
in effectSec. 82-517. - Animals used in processing.
(a) Care of animals used in processing. Caretakers and attendants for animals used for the processing of products shall be sufficient in number and have adequate experience to ensure adequate care. Animal quarters and cages shall be kept in sanitary condition. Animals on production shall be inspected daily to observe response to production procedures. Animals that become ill for reasons not related to production shall be isolated from other animals and shall not be used for production until recovery is complete. Competent veterinary care shall be provided as needed.
(b) Quarantine of animals generally. No animal shall be used in processing unless kept under competent daily inspection and preliminary quarantine for a period of at least seven days before use, or as otherwise provided in this article. Only healthy animals free from detectable communicable diseases shall be used. Animals must remain in overt good health throughout the quarantine periods and particular care shall be taken during the quarantine periods to reject animals of the equine genus which may be infected with glanders and animals which may be infected with tuberculosis.
(c) Quarantine of monkeys. In addition to observing the pertinent general quarantine requirements, monkeys used as a source of tissue in the processing of vaccine shall be maintained in quarantine for at least six weeks prior to use; except when otherwise provided in this part. Only monkeys that have reacted negatively to tuberculin at the start of the quarantine period and again within two weeks prior to use shall be used in the processing of vaccine. Due precaution shall be taken to prevent cross-infection from any infected or potentially infected monkeys on the premises. Monkeys to be used in the processing of a live vaccine shall be maintained throughout the quarantine period in cages closed on all sides with solid materials except the front which shall be screened, with no more than two monkeys housed in one cage. Cage mates shall not be interchanged.
(d) Immunization against tetanus. Horses and other animals susceptible to tetanus, that are used in the processing steps of the processing of biological products shall be treated adequately to maintain immunity to tetanus.
(e) Immunization and bleeding of animals used as a source of products. Toxins or other nonviable antigens administered in the immunization of animals used in the processing of products shall be sterile. Viable antigens, when so used, shall be free of contaminants, as determined by appropriate tests prior to use. Injections shall not be made into horses within six inches of bleeding site. Horses shall not be bled for processing purposes while showing persistent general reaction or local reaction near the site of bleeding. Blood shall not be used if it was drawn within five days of injecting the animals with viable microorganisms. Animals shall not be bled for processing purposes when they have an intercurrent disease. Blood intended for use as a source of biological product shall be collected in clean, sterile vessels. When the product is intended for use by injection, such vessels shall also be pyrogen-free.
(f) Reporting of certain diseases. In cases of actual or suspected infection with foot-and-mouth disease, glanders, tetanus, anthrax, gas gangrene, equine infectious anemia, equine encephalomyelitis or any of the pock diseases among animals intended for use or used in the processing of products, the processor shall immediately notify the director of the department of health.
(g) Monkeys used previously for experimental or test purposes. Monkeys that have been used previously for experimental or test purposes with live microbiological agents shall not be used as a source of kidney tissue for the processing of vaccine. Except as provided otherwise in this division, monkeys that have been used previously for other experimental or test purposes may be used as a source of kidney tissue upon their return to a normal condition, provided all quarantine requirements have been met.
(h) Necropsy examination of monkeys. Each monkey used in the manufacture of vaccine shall be examined at necropsy under the direction of a qualified pathologist, physician or veterinarian having experience with diseases of monkeys, for evidence of ill health, particularly for:
(1) Evidence of tuberculosis;
(2) Presence of herpes-like lesions, including eruptions or plaques on or around the lips, in the buccal cavity or on the gums; and
(3) Signs of conjunctivitis.
If there are any such signs or other significant gross pathological lesions, the tissue shall not be used in the processing of vaccine.
(Code 1956, § 29-103(f))
Source: City of New Orleans, Code of Ordinances and Home Rule Charter (Municode Library, library.municode.com)URL: https://library.municode.com/la/new_orleans/codes/code_of_ordinances?nodeId=PTIICO_CH82HESA_ARTXISTOPBLBAPLCE_DIV3RE_S82-517ANUSPRFetched: 10/28/2026
